Session Details
[28P-am]Pharmacotherapies (Basics, Clinical, Cancer)/Appropriate use of medicines (including drug-drug interations)/Community pharmacy, home medical care, and community health care/Pharmacoepidemiology, Health economics/Others
Fri. Mar 28, 2025 8:30 AM - 12:00 PM JST
Fri. Mar 28, 2025 11:30 PM - 3:00 AM UTC
Fri. Mar 28, 2025 11:30 PM - 3:00 AM UTC
Poster (MARINE MESSE FUKUOKA Hall B: Exhibition Room [1F])
[28P-am435]Differences in the rates of using medical notebooks depending on gender and age group
○Youhei Saito1, Mai Matono2, Masahiko Tsuji2, Emi Shibata2, Arisa Nakagawa2, Miyu Matsuda2, Yuki Hiraoka2, Yoshiteru Mikami2, Akihiro Sakabe2, Ryuzaburo Yuki1, Yuji Nakayama1, Takamasa Yamaguchi2, Mitsutoshi Uno2 (1. Kyoto Pharm. Univ., 2. U Yakkyoku Group)
[28P-am436]Evaluation and improvement of patient education materials through a patient survey: Focus on Brimonidine tartrate eye drops and antihypertensives interactions
○Tadayoshi Shibata1,2, Tomoya Sakurada1, Nobunori Satoh1 (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Momotaro Pharmacy, Togen Ltd.)
[28P-am437]Characteristic Extraction of Nutrition Counseling by Registered Dietitians: A Text Mining Approach
○Nana Komiya1, Akira Yoshida2, Shinji Oshima2, Yutaka Inoue2 (1. herbland Pharm., 2. Josai Univ.)
[28P-am438]Impact of walking exercise on renal function in diabetes outpatients
○Takayoshi Maiguma1,2, Hisashi Asada2, Shouta Yamanashi1, Yushi Yamaki1, Keisuke Yoshii1, Kenichi Shimada1,2 (1. Sch. Pharm., Shujitsu Univ., 2. Grad. Sch. Clin. Pharm., Shujitsu Univ.)
[28P-am439]Efficacy of a Smartphone-Based Medication Support Tool in Community Pharmacies for Improving Medication Adherence: A Randomized Controlled Trial
○Yukiko Tateyama1, Shimamoto Tomonari2, Iwami Taku1 (1. Department of Preventive Services, Graduate School of Medicine, Kyoto University, 2. Department of Implementation Science in Public Health, Graduate School of Medicine, Kyoto University)
[28P-am440]Establishment and evaluation of a wide-area pre-dispensing agreement in northern area of Osaka prefecture
○Tomoya Yamamoto1,9, Mitsunori Nishikawa1, Kazuaki Kojima2,9, Keisi Imanishi3,9, Masayoshi Matsuura4,9, Keiko Nakamura5,9, Nobuyuki Kato4,9, Toshiko Okamura6,9, Kouji Ishida7,9, Yoshihiro Miyake8,9, Masahiro Okuda1,9 (1. Department of pharmacy, Osaka university Hospital, 2. Department of pharmacy, Takatsuki Red Cross Hospital, 3. Minoh City Pharmacists Association, 4. Ibaraki City Pharmacists Association, 5. Ikeda-Shi Pharmacist society, 6. Suita Pharmaceutical Association, 7. Settsu City Pharmacists Association, 8. Takatsuki City Pharmaceutical Association, 9. Toyono-Mishima Area Pharmaceutical Coalition Council)
[28P-am441]Survey of pharmaceutical interventions by analyzing adverse event report data
○ATSUSHI KODAKA1, MAMI SETO1, YUICHI ASAMI1, HIROFUMI MORI1, TAKAYASU ITO1, TOSHIMI IIZUKA1 (1. Bohsei Pharmacy)
[28P-am442]A research study on adherence, efficacy and safety of oral GLP-1 receptor agonist Rybelsus® (Semaglutide) tablets.
○Fumie Kato1, Chihiro Ito1, Takuto Inoue1, Tatsuro Satomi2, Shinji Kasai2, Ken-yuh Hasumoto1, Keiko Hosohata1 (1. Himeji Dokkyo University, 2. Ebira Pharmacy)
[28P-am443S]The utility and evaluation of MPASS (Meiji Pharmaceutical Adversed reaction Search System) in insurance pharmacies
○Miu Kinoshita1, Nobuyuki Kanno1, Noguchi Tamotsu1, Tominaga Daisuke1 (1. Meiji Pharmaceutical University)
[28P-am444S]Exploration of associated factors in oral mucositis in cancer patients~Analysis focusing on oral dryness and salivary inflammatory mediators~
○Nana Okamoto1, Kensuke Yoshida1, Anna Kiyomi1, Akira Kurokawa2, Naoto Hoshino3, Chie Saito3, Masayoshi Koga3, Hiroko Kanemaru3, Munetoshi Sugiura1 (1. Tokyo University of Pharmacy , 2. Niigata University Medical and Dental Hospital, 3. Niigata University Medical and Dental Hospital)
[28P-am445]A Case of Cholinergic Symptoms with Low Cholinesterase Activity After Exposure to the Pesticide Emamectin Benzoate Emulsion (Affirm Emulsion)
○Hideo Chubachi1, Noritaka Kitazume1, Satoshi Ogura2, Masayuki Miyazawa3, Haruka Kamagata2 (1. Dept.Pharm.,Shonan-Fujisawa Tokushukai Hospital , 2. Shonan-Fujisawa Tokushukai Hospital Medical office, 3. Dept.Pharm.,Fujisawa City Hospital)
[28P-am446S]Effect of semi-solid enteral nutrition product ingredients on levetiracetam concentrations.
○Yusuke Imazawa1, Yoko Urashima1, Yoshitaka Arai1, Hato Koushi1, Airi Yamasaki1, Kazuya Urashima2, Tomoyuki Yamada3, Kazumi Kurachi3, Masami Nishihara3, Masashi Neo3, Kazuki Umemoto1, Tokio Obata1 (1. Pharm., Osaka Ohtani Univ., 2. Pharm., JCHO Osaka Minato Center Hosp., 3. Pharm., Osaka Med. and Pharm. Univ. Hosp.)
[28P-am447S]The effect of concomitant use of Kampo on the gastrointestinal absorption of theophylline
○Junya Takahashi1, Kazuki Umemoto1, Yoko Urashima1, Tokio Obata1 (1. Pharm., Osaka Ohtani Univ)
[28P-am448S]The effect of short-term storage conditions on the quality of fluorometholone aqueous suspension ophthalmic solution
○Chika Kamine1, Kazuki Umemoto1, Yoko Urashima1, Hidemasa Katsumi1, Hiroko Otake2, Kouichi Hosomi2, Noriaki Nagai2, Tokio Obata1, Yuichiro Nakada1 (1. Pharm., Osaka Ohtani Univ, 2. Pharm., Kindai Univ)
[28P-am449S]Analysis of oxidoreductases in exosomes derived from raw milk and pasteurized milk
○Ayaka Iwakiri1, Riko Tsunoda1, Mai Sekine 1, Yujiro Hagita2, Nobuhito Hamano1, Hiroshi Ishihara1 (1. TUPLS, 2. NVLU)
[28P-am450S]Effects of semisolid enteral nutrition products and thickening agents on gastrointestinal absorption of sodium valproate in rats
○Airi Yamasaki1, Yoko Urashima1, Hato Koushi1, Yoshitaka Arai1, Yusuke Imazawa1, Kazuya Urashima2, Tomoyuki Yamada3, Kazumi Kurachi3, Masami Nishihara3, Masashi Neo3, Kazuki Umemoto1, Tokio Obata1 (1. Pharm., Osaka Ohtani Univ., 2. Pharm., JCHO Osaka Minato Center Hosp., 3. Osaka Med. and Pharm. Univ. Hosp.)
[28P-am451S]Impact of proton pump inhibitors on the antitumor efficacy of capecitabine in a murine tumor model.
○Ryoma Okimura1, Hitoshi Kawazoe2, Kosuke Nakamichi1, Masahiro Akiyama3, Yun-Gi Kim4, Tomonori Nakamura1 (1. Keio Univ. Fac. Pharm., 2. Keio Univ. Sch. Med., 3. Showa Univ. Clin. Res. Inst., 4. Kitasato Univ. Fac. Pharm.)
[28P-am452]The antinociceptive effects of Boiogito and sinomenine: A behavioral pharmacological study.
○Soh Katsuyama1, Fumihide Takano1, Hiroki Kataoka1, Toshiaki Saitoh1, Naoko Okada1, Chikai Sakurada1 (1. Nihon.Pham.Univ.)
[28P-am453]Preventive Effect of Cannabidiol on Disuse Muscle Atrophy
○HIROMASA KATO1, SARA OGURO1, IORI URATUJI1, RINA OOKAWA1, RENA TOKIZAKI1, WATARU OCHIAI1 (1. Hoshi Univ)
[28P-am454]Effects of blood and brain Midazolam concentrations on prolonged sedation in rats with low albumin levels
○TAKAAKI YANO1,2, Shinichi Watanabe2, Ginjiro Kato2, Hidemichi Mitome2, Yuta Toge1, Mayu Morita1, Noriaki Hidaka1, Kazuki Akira2, Mamoru Tanaka1 (1. Div. Pharm., Ehime Univ. Hosp., 2. Grad. Sch. Pharm. Sci., Matsuyama Univ.)
[28P-am455S]Effects of the combined administration of fingolimod (FTY720) to allergen immunotherapy on antibody titers
○Hiroki Urakawa1, Ryohei Shibao1, Yuzuki Konno1, Hikaru Fuchita1, Norihisa Mikami2,3, Hirohito Kita4, Yuya Yoshida1, Takumi Tsuji1 (1. Fac. Pharm Setsunan Univ, 2. IFReC, Osaka Univ, 3. LiMe, Kyoto Univ, 4. Mayo Clinic)
[28P-am456S]Effect of prophylactic sublingual administration of allergens to ovalbumin epicutaneously sensitized allergy model mice
○Ryohei Shibao1, Hiroki Urakawa1, Yuzuki Konnno1, Hikaru Fuchita1, Norihisa Mikami2,3, Hirohito Kita4, Yuya Yoshida1, Takumi Tsuji1 (1. Fac. Pharm. Sci., Setsunan Univ., 2. IFRec, Osaka Univ., 3. LiMe, Kyoto Univ., 4. Mayo Clinic)
[28P-am457S]Impact of co-administration of live biotherapeutic product on the antitumor effects of immune checkpoint inhibitor in mice
○Anna Okada1, Hitoshi Kawazoe2, Kosuke Nakamichi1, Masahiro Akiyama3, Yun-Gi Kim4, Tomonori Nakamura1 (1. Keio Univ. Fac. Pharm., 2. Keio Univ. Sch. Med., 3. Showa Univ. Clin. Res. Inst., 4. Kitasato Univ. Fac. Pharm.)
[28P-am458S]Growth of Candida spp. in fat-containing and fat-free PPN injection
○Kodai Kawahara1, Yuka Nagatsuka1, Sayaka Ban2, Yuhki Sato1 (1. Fac. Pharm. Pharmaceut. Sci., Fukuyama Univ., 2. Med. Mycol. Res. Ctr., Chiba Univ.)
[28P-am459S]Antifungal susceptibility of pathogenic and non-pathogenic Candida spp. related to C. albicans and its similarity
○Yudai Tsuruta1, Yuka Nagatsuka1, Yuhki Sato1 (1. Fac. Pharm. Pharmaceut. Sci., Fukuyama Univ.)
[28P-am460]Enhancement of Oral Absorption of Tetrahydrocurcumin through Water-Soluble Prodrug Strategy
○Masako Harada1, Hirofumi Yamakawa2, Shuichi Setoguchi2, Shotaro Goto2, Kazuhisa Matsunaga2 (1. Grad. Pharm. Sci., Fukuoka Univ., 2. Faculty of Pharm. Sci., Fukuoka Univ.)
[28P-am461S]Suppressive effects of isoprenoid quinone esters on ferroptosis
○touya nanri1, Masako Harada 2, Shotaro Goto1, Shuichi Setoguchi1, Kazuhisa Matsunaga1 (1. Pharm. Sci., Fukuoka Univ., 2. Grad. Sch. Pharm. Sci., Fukuoka Univ.)
[28P-am462S]The growth inhibitory effect of derivative of reduced vitamin K2 on Gefitinib-resistant A549 cells
○Katsuto Nakao1, Sho Kurano1, Daiki Mori1, Masako Harada2, Shotaro Goto1, Shuichi Setoguchi1, Kazuhisa Matsunaga1 (1. Pharm. Sci., Fukuoka Univ., 2. Grad. Sch. Pharm. Sci., Fukuoka Univ.)
[28P-am463S]Evaluation of the effect of vitamin K2 on epithelial-mesenchymal transition (EMT) in Gefitinib-resistant A549 cells
○Sho Kurano1, Daiki Mori1, Masako Harada2, Shotaro Goto1, Shuichi Setoguchi1, Kazuhisa Matsunaga1 (1. Pharm. Sci., Fukuoka Univ., 2. Grad. Sch. Pharm. Sci., Fukuoka Univ.)
[28P-am464S]Analysis of epithelial-mesenchymal transition (EMT) -related proteins in Gefitinib-resistant A549 cells using targeted proteomics
○Daiki Mori1, Sho Kurano1, Masako Harada2, Shotaro Goto1, Shuichi Setoguchi1, Kazuhisa Matsunaga1 (1. Pharm. Sci., Fukuoka Univ., 2. Grad. Sch. Pharm. Sci., Fukuoka Univ.)
[28P-am465S]Semaglutide Adherence and Cardiovascular Diseases in Patients with Type 2 Diabetes: Evidence from Real-World Data in Japan
○Ririka Suzuki1, Chikako Masudo1, Takeshi Horii1, Yukari Ogawa1, Jyunichi Tajima1, Akito Nishimuta1, Katsutoshi Yuasa1, Haruta Koshimizu1, Yoshihiro Takao1, Kiyoshi Mihara1 (1. Department of Pharm., Musashino Univ.)
[28P-am466]Investigation of appropriate intake of SGLT2 inhibitor for night shift workers with diabetes
○Aya Torii1, Minami Hirose1, Kazumi Shiomi2, Masatoshi Murase2, Junko Ito2, Hiroki Yoshioka3, Yasuro Shinohara1, Masae Yoshikawa1 (1. Dept. Pharm., Kinjo Gakuin Univ., 2. Ito Physical Clinic, 3. Dept. Pharm., Gifu Univ. Med. Sci.)
[28P-am467]Risk Factors for Treatment Transition in Patients with Low-Risk Atrial Fibrillation Patients Undergoing Anticoagulation Monotherapy: A Large Claims Database Study in Japan
○Haruki Funakoshi1,2, Yoshihiro Kiryu3, Kenji Momo1 (1. Dep of Hosp Pharm, Sch of Pharm, Showa Univ, 2. Showa Univ Hosp, 3. Medica Staff Promo Co.,Ltd. Devel Dep of Medical Info/ Pharma Info Systems)
[28P-am468]Analysis of Dotinurad Usage by Renal Function at Our Institution
○Ryo Sato1, Takeshi Takeda1, Keiko Abe1 (1. Nihonkai General Hospital)
[28P-am469]Investigation of the Relationship between Blood Concentration of Bisoprolol and Heart Rate
○Hiroyuki Motoishi1,2, Naoya Kimura2, Hiroshi Inagaki3, Reiko Nozawa-Ishii1 (1. Meiji Pharm. Univ., 2. Dept. Pharm., Soka Municipal Hosp., 3. Dept. Cardiol., Soka Municipal Hosp.)
[28P-am470]Association between blood neutrophil and eosinophil counts with treatment failure in patients with acute exacerbation of chronic obstructive pulmonary disease
○Noriko Kohyama1, Kuniaki Hirai2, Tetsuya Honma2, Hironori Sagara2, Miki Sato1, Masayuki Ohbayashi1, Mari Kogo1 (1. Showa Univ. Grad. Sch. Pharm., 2. Showa Univ. Sch. Med.)
[28P-am471]Characteristics of causative drugs and clinical profiles in severe cutaneous adverse drug reactions.
○Eri Tsukagoshi1, Ryosuke Nakamura1,2, Nahoko Kaniwa1, Kimie Sai1, Kayoko Matsunaga3, Riichiro Abe4, Hideo Asada5, Yoshiro Saito1, Ruri Kikura-Hanajiri1 (1. NIHS, 2. Pharm. Sci., Teikyo Univ., 3. Fujita Health Univ., 4. Med. Sci., Niigata Univ., 5. Nara Medical Univ.)
[28P-am472]Study on Pharmacists' Roles and Participation in Hospital Emergency Calls (Second Report)
○Akari Orui1, Ikko Hirata1,2, Yunosuke Tanaka1, Eri Sukegawa1, Tomo Sugano1, Ryokan Funakoshi1,3 (1. Department of Pharmacy, Kameda General Hospital , 2. Department of Pharmacy, Kameda Clinic, 3. Department of Drugs Control, Kameda General Hospital)
[28P-am473S]Changing score of the Edinburgh Postnatal Depression Scale among pregnant women who received pharmacist counseling
○Yuina Yano1, Miyuki Murata1, Serika Ozeki1, Natsuki Masumori1, Hideaki Suzuki2, Norio Takimoto2, Aya Torii1, Masae Yoshikawa1 (1. Dept. Pharm. Kinjo Gakuin Univ., 2. Department of Pharmacy, Kariya Toyota General Hospital)
[28P-am474S]Changing score of the Edinburgh Postnatal Depression Scale among pregnant women taking psychotropics during pregnancy
○Miyuki Murata1, Yuina Yano1, Serika Ozeki1, Natsuki Masumori1, Hideaki Suzuki2, Norio Takimoto2, Mayuko Sakanashi1, Aya Torii1, Masae Yoshikawa1 (1. Dept. Pharm. Kinjo Gakuin Univ., 2. Department of Pharmacy, Kariya Toyota General Hospital)
[28P-am475]A severe tremor caused by a beta2 agonist in a patient with asthma-chronic obstructive pulmonary disease overlap
○Kota Nakajima1,2, Kenji Momo2 (1. Dep. Pharm., Showa Univ Hosp., 2. Sch. Pharm., Showa Univ.)
[28P-am476]A case of non-cancerous dyspnea treated with one-dose dispensing of morphine water
○Toshiaki Fujioka1, Akiko Yamane1 (1. PHARMACY Co.Ltd.)
[28P-am477]Detection of early cancer-associated thrombosis using breast cancer 4T1-bearing mice
○Riyo Morimoto-Kamata1, Yuichi Kamikubo2, Naoki Ohta1, Lisa Munakata1, Ryo Suzuki1, Saori Kageyama1, Kazuo Maruyama1, Naoki Ohkura1 (1. Dep. of Pharm.Sci., Teikyo Univ., 2. Thrombo Translational Research Lab In.)
[28P-am478]Targeting fatty acid metabolism enhance the anti-cancer effects of kinase inhibitors in leukemia.
○Takuya Hirao1, Yoshinori Kato1,2, Chihiro Tetsuka1, Harumi Yamada1,2 (1. Sch. Pharm. Sci., Int. Univ. Health and Welfarefare, 2. Grad. Sch. Pharm. Sci., Int. Univ. Health and Welfarefare)
[28P-am479S]Inhibitory effect of cell growth by treatment of arctigenin from Arctium lappa.
○Yuuka Maeda1, Nao Kawasaki1, Shinya Okubo1,2, Shigeru Oiso1,2 (1. Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University, 2. Graduate School of Pharmaceutical Sciences, Nagasaki International University)
[28P-am480S]Arctigenin from Arctium lappa exerts a cancer cell-specific anti-proliferative effect with short-term treatment.
○Yuka Hirao1, Nao Kawasaki1, Shinya Okubo1,2, Shigeru Oiso1,2 (1. Department of Pharmacy, Faculty of Pharmaceutical Sciences, Nagasaki International University, 2. Graduate School of Pharmaceutical Sciences, Nagasaki International University)
[28P-am481S]Novel therapeutic approaches targeting monocarboxylate transporters to overcome treatment resistance in hepatocellular carcinoma
○Yuto Mukai1, Atsushi Yamaguchi1,2, Yudai Suganuma1, Noriyuki Matsumoto1, Keisuke Okamoto1, Ayako Furugen1, Katsuya Narumi1, Masaki Kobayashi1 (1. Grad. Sch. Pharm. Sci., Hokkaido Univ., 2. Dept. Pharm., Hokkaido Univ. Hosp.)
[28P-am482S]A Survey on Hospital Pharmacists' Awareness and Knowledge of Medication-Related Osteonecrosis of the Jaw
○Saya Watanabe1, Yosuke Iijima2, Miki Yamada2, Kenta Ushikubo2, Mai Amano1, Shunsuke Hino2, Hiroyuki Ohya3, Mashu Morimoto3, Norio Horie2, Takahiro Kaneko2, Masami Kondo3, Motohiko Sano1 (1. Division of Applied Pharmaceutical Education and Research Hoshi University, 2. Department of Oral and Maxillofacial Surgery, Saitama Medical Center, Saitama Medical University, 3. Department of Pharmacy Services, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan)
[28P-am483S]Regulation of MICA/ADAM-9 mRNA expression in HepG2 cells
○Rina Seishi1, Yasuaki Tatsumi1, Koji Higai1 (1. Toho university)
[28P-am484S]Expression of MICA/ADAM-9 mRNA on HepG2-stimulated with IL-1β
○Kenta Anzo1, Erika Ishi1, Nanako Kawasaki1, Yasuaki Tatsumi1, Koji Higai1 (1. Toho university)
[28P-am485S]Influence of CYP3A4 conduction caused by enzalutamide gives myelosuppression caused by docetaxel
○Bian Tanaka1, Shota Torii2, Aya Torii1, Takashi Sakakibara2, Norio Takimoto2, Takahiro Hayashi1 (1. Pharm. Kinjo Gakuin Univ., 2. Pharm. Kariya Toyota General Hospital)
[28P-am486]Chemical Permeation and Concentration in Medical Gloves Used by Healthcare Workers
○Megumi Watanabe1, Takeshi Osizaka1, Takuya Sootome2, Tomoaki Toyama2, Keiko Shinozaki2, Satoru Usui2, Kennji Mori1, Kennji Sugibayashi1 (1. Faculty of pharm. Sci.,Josai international Univ., 2. Dokkyo Medical Univ.Hospital)
[28P-am487S]Study on disintegration and dissolution properties of drugs containing tranexamic acid-containing ingredients
○Anna Ishigaki1, Shuri Maeda1, Yuka Miyachi1, Yukina Miyagi1,2, Saori Gocho2,3, Chika Nakayama4, Taeyuki Oshima1 (1. College of Pharmacy, Kinjo Gakuin University, 2. Graduate School of Medicine, Aichi Medical University, 3. Department of Pharmacy, Nagoya Ekisaikai Hospital, 4. Faculty of Pharmacy, Gifu University of Medical Science)
[28P-am488]The current status of Advance Care Planning (ACP) in cancer patient : Multi-hospital surveyⅠ
○Yuka Miyachi1, Iroha Kamiya1, Yukina Miyagi1,2, Chika Nakayama3, Saori Gocho2,4, Masami Inagaki4, Yumiko Goto5, Masafumi Onishi5, Satoshi Nakamura6, Yoshiaki Hattori6, Taeyuki Oshima1 (1. College of Pharmacy, Kinjo Gakuin University, 2. Graduate School of Medicine, Aichi Medical University, 3. Faculty of Pharmacy, Gifu University of Medical Science, 4. Department of Pharmacy, Nagoya Ekisaikai Hospital, 5. Department of Pharmacy, Aichi Medical University Hospital, 6. Department of Pharmacy, Kasugai Municipal Hospital)
[28P-am489S]The current status of Advance Care Planning (ACP) in cancer patient : Multi-hospital survey Ⅱ
○Iroha Kamiya1, Yuka Miyachi1, Yukina Miyagi1,2, Chika Nakayama3, Saori Gocho2,4, Masami Inagaki4, Yumiko Goto5, Masafumi Onishi5, Satoshi Nakamura6, Yoshiaki Hattori6, Taeyuki Oshima1 (1. College of Pharmacy, Kinjo Gakuin University, 2. Graduate School of Medicine, Aichi Medical University, 3. Faculty of Pharmacy, Gifu University of Medical Science, 4. Department of Pharmacy, Nagoya Ekisaikai Hospital, 5. Department of Pharmacy, Aichi Medical University Hospital, 6. Department of Pharmacy, Kasugai Municipal Hospital)
[28P-am490S]Analysis of “Shinsa-Joho-Teikyo-Jirei” regarding off-label use of pharmaceuticals
○Aika Hazama1, Mamoru Narukawa1 (1. Grad. Sch. Pharm. Sci., Kitasato Univ.)
[28P-am491]A fatal case due to inappropriate use of foreign-made torsemide
○Akina Nara1, Chiho Yamada1, Yu Kozakai1, Manami Suyama1, Tetsuya Takagi1 (1. Leg Med., TMPU)
[28P-am492]Survey on the shortage of pharmacists at Japanese Red Cross Hospitals and reform of profit structure
○Hideki Mori1, tukasa kimata2, yuki kumihasi3, masanori iga4, mituru matida5 (1. Japanese Red Cross Okayama Hospital , 2. Japanese Red Cross nagoya2 Hospital , 3. Japanese Red Cross tokusima Hospital , 4. Japanese Red Cross , 5. Japanese Red Cross saitama Hospital)
[28P-am493S]Effectiveness and safety of oral propranolol in patients aged 0–18 years: a retrospective study.
○Kokomi Matsumoto1, Saki Yoshinaka1, Mami Kubota1, Jumpei Saito2, Miki Akabane2, Akimasa Yamatani1, Manabu Akazawa1 (1. Meiji Pharmaceutical University, 2. Department of Pharmacy, National Center for Child Health and Development)
[28P-am494S]Efficacy of prophylactic administration of PC-SOD for oxaliplatin-dependent leukopenia
○Ayano Shikata1, Mikako Shimoda1, Yusuke Murakami1,2, Masahiro Kawahara1,2, Tohru Mizushima3, Kenichiro Tanaka1,2 (1. Musashino Univ., Fac. Pharm., 2. Musashino Univ., Res. Ins. Pharm. Sci., 3. LTT Bio-Pharma Co., Ltd)
[28P-am495]Biological significance of CRMP1 de novo variants in autism spectrum disorder.
○hiroko makihara1, yumi yano1, suzuna sato1, fumio nakamura1 (1. Sch. Med., Tokyo Women's Medical Univ.)
[28P-am496]Development of an antimicrobial susceptibility assay for Pseudomonas aeruginosa using pre-rRNA
○Hideaki Yashima1, Takuya Araki1, Koujirou Yamamoto1 (1. Grad. Sch. Med., Gunma Univ)
[28P-am497S]Assessment of the impact of vancomycin-induced acute kidney injury on 30-day in-hospital mortality, length of stay, and healthcare costs using JMDC hospital data.
○Azusa Ishiyama1, Shutaro Murakami1,2, Kotona Hirose1, Sayuri Otogawa1, Koga Miyahara1, Ryoko Sakai1, Manabu Akazawa1 (1. Meiji pharmaceutical University, 2. Tokyo Metropolitan Tama Medical Center)
[28P-am498S]Characteristics of the patients with rheumatoid arthritis who developed malignancy
○Yui Maeda1, Ryoko Sakai1, Manabu Akazawa1 (1. Meiji pharmaceutical University)
[28P-am499S]Prescription Patterns of Attention-deficit Hyperactivity Disorder Medications using a large-scale claims database
○Takumi Miyoshi1, Ryutaro Suzuki1,2, Junsei Tanaka1, Ryosuke Kumazawa1, Ryoko Sakai1, Manabu Akazawa1 (1. Meiji pharmaceutical University, 2. Kitasato University School of Medicine)
[28P-am500S]Evaluation of the Risk of Pancreatic Cancer Associated with Dipeptidyl Peptidase-4 Inhibitors Using the Prevalent User : A Methodological Investigation in Epidemiology
○Manato Yoshida1, Takuma Koinuma2, Manabu Akazawa 1 (1. Meiji Pharmaceutical University, 2. Tokyo University of Pharmacy and Life Sciences)